Jeremy Hollings joined Ropes & Gray’s corporate department in 2023. During law school, he volunteered for Boston College Law School’s Covid Relief Legal Services and served as a senior editor for the Boston College Law Review.

Experience

  • Represented holders of $2.4 billion of convertible notes issued by Wolfspeed, Inc. (NYSE: WOLF), a global leader in silicon carbide technology, in connection with its confirmed prepackaged chapter 11 plan of reorganization.
  • Represented CAMP4 Therapeutics in its $75 million initial public offering and its $100 million PIPE offering.
  • Represented National Amusements, Inc. in its $2.4 billion sale to entities affiliated with the Ellison family and RedBird Capital.
  • Represented the underwriters in multiple secondary offerings totaling approximately $4.5 billion of stock of Nasdaq, Inc.
  • Represented Alnylam Pharmaceuticals, Inc. in its $661.25 million convertible notes offering.
  • Represented the underwriters in Rhythm Pharmaceuticals’ $200 million equity offering.
  • Represented The Hanover Insurance Group, Inc. in its $500 million registered debt offering.
  • Represented the underwriters in Two Harbors Investment Corp.’s $115 million baby bond offering.
  • Represented the underwriters in Tampa Electric Company’s $600 million IG registered notes offering.
  • Represented the sales agents in Orchid Island Capital, Inc.’s $350 million at-the-market offering.
  • Represented Apollo Debt Solutions BDC in its $400 million 144A bond offering.
  • Represented the initial purchasers in MSD Investment Corp.’s $500 million 144A bond offering.
  • Represented the underwriters in Goldman Sachs BDC, Inc.'s $400 million registered debt offering.
  • Ongoing representation of public company clients in connection with securities law and corporate governance matters.

Areas of Practice